Jazz Pharmaceuticals

Activities: Pharmaceutical

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Jazz Pharmaceuticals announces UK manufacturing investment

Due to open in 2024, the facility is designed to support the company’s two cannabis-based medicines and support future capacity for medicines under development
Regulatory

Hikma enters settlement agreement with Jazz for sodium oxybate

Jazz will grant Hikma and West-Ward the right to sell an authorised generic of Xyrem in the US
Design & Build

Jazz Pharmaceuticals among ISPE FOYA winners

Ardmac supplied and installed the cleanroom in the biopharmaceutical company's winning facility in Ireland
Finance

Jazz Pharmaceuticals buys Alize Pharma II for €18m

Alize Pharma II is developing treatments for acute lymphoblastic leukaemia
Pharmaceutical

Jazz Pharmaceuticals names Russell Cox as Chief Operating Officer

Cox was formerly EVP and Chief Commercial Officer at the biopharmaceuticals company
Manufacturing

Jazz Pharmaceuticals to build new manufacturing and development facility in Ireland

It is expected to open in 2016 and create up to 50 new jobs when fully operational
Ingredients

Jazz Pharmaceuticals moves to buy EUSA Pharma

Terms include $650 million in cash plus a potential $50 m milestone payment
Subscribe now